Wall Street is positive on Sio Gene Therapies Inc (SIOX). On average, analysts give Sio Gene Therapies Inc a Strong Buy rating. The average price target is $8.583, which means analysts expect the stock to climb by 472.20% over the next twelve months. That average ranking earns Sio Gene Therapies Inc an Analyst Rating of 74, which is better than 74% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating SIOX a Strong Buy today. Find out what this means to you and get the rest of the rankings on SIOX!